JP2021511047A5 - - Google Patents

Info

Publication number
JP2021511047A5
JP2021511047A5 JP2020539779A JP2020539779A JP2021511047A5 JP 2021511047 A5 JP2021511047 A5 JP 2021511047A5 JP 2020539779 A JP2020539779 A JP 2020539779A JP 2020539779 A JP2020539779 A JP 2020539779A JP 2021511047 A5 JP2021511047 A5 JP 2021511047A5
Authority
JP
Japan
Prior art keywords
itr
sense
item
expression cassette
stranded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020539779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021511047A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/014122 external-priority patent/WO2019143885A1/en
Publication of JP2021511047A publication Critical patent/JP2021511047A/ja
Publication of JP2021511047A5 publication Critical patent/JP2021511047A5/ja
Priority to JP2023116157A priority Critical patent/JP2023126487A/ja
Priority to JP2025084944A priority patent/JP2025113389A/ja
Pending legal-status Critical Current

Links

JP2020539779A 2018-01-19 2019-01-18 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス Pending JP2021511047A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023116157A JP2023126487A (ja) 2018-01-19 2023-07-14 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス
JP2025084944A JP2025113389A (ja) 2018-01-19 2025-05-21 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862619392P 2018-01-19 2018-01-19
US62/619,392 2018-01-19
PCT/US2019/014122 WO2019143885A1 (en) 2018-01-19 2019-01-18 Closed-ended dna vectors obtainable from cell-free synthesis and process for obtaining cedna vectors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023116157A Division JP2023126487A (ja) 2018-01-19 2023-07-14 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス

Publications (2)

Publication Number Publication Date
JP2021511047A JP2021511047A (ja) 2021-05-06
JP2021511047A5 true JP2021511047A5 (cg-RX-API-DMAC7.html) 2022-02-24

Family

ID=67301565

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020539779A Pending JP2021511047A (ja) 2018-01-19 2019-01-18 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス
JP2023116157A Withdrawn JP2023126487A (ja) 2018-01-19 2023-07-14 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス
JP2025084944A Pending JP2025113389A (ja) 2018-01-19 2025-05-21 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023116157A Withdrawn JP2023126487A (ja) 2018-01-19 2023-07-14 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス
JP2025084944A Pending JP2025113389A (ja) 2018-01-19 2025-05-21 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス

Country Status (16)

Country Link
US (1) US12442015B2 (cg-RX-API-DMAC7.html)
EP (1) EP3740571A4 (cg-RX-API-DMAC7.html)
JP (3) JP2021511047A (cg-RX-API-DMAC7.html)
KR (2) KR20250159738A (cg-RX-API-DMAC7.html)
CN (1) CN111868242A (cg-RX-API-DMAC7.html)
AU (1) AU2019210034B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020013319A2 (cg-RX-API-DMAC7.html)
CA (1) CA3088984A1 (cg-RX-API-DMAC7.html)
IL (1) IL275878B2 (cg-RX-API-DMAC7.html)
MA (1) MA51626A (cg-RX-API-DMAC7.html)
MX (1) MX2020005790A (cg-RX-API-DMAC7.html)
MY (1) MY208589A (cg-RX-API-DMAC7.html)
PH (1) PH12020550878A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202005271TA (cg-RX-API-DMAC7.html)
UA (1) UA130154C2 (cg-RX-API-DMAC7.html)
WO (1) WO2019143885A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001593A (es) 2017-08-09 2020-07-13 Bioverativ Therapeutics Inc Moleculas de acido nucleico y usos de las mismas.
AU2019221642A1 (en) * 2018-02-14 2020-07-09 Generation Bio Co. Non-viral DNA vectors and uses thereof for antibody and fusion protein production
JP7602454B2 (ja) 2018-08-09 2024-12-18 バイオベラティブ セラピューティクス インコーポレイテッド 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
WO2020097417A1 (en) * 2018-11-09 2020-05-14 Generation Bio Co. Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeats
GB201905651D0 (en) 2019-04-24 2019-06-05 Lightbio Ltd Nucleic acid constructs and methods for their manufacture
WO2021011842A1 (en) 2019-07-17 2021-01-21 Generation Bio Co. Synthetic production of single-stranded adeno associated viral dna vectors
DE102020111571A1 (de) 2020-03-11 2021-09-16 Immatics US, Inc. Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
IL296660A (en) * 2020-03-24 2022-11-01 Generation Bio Co Non-viral DNA vectors and their use for therapeutic expression of factor ix
MX2023001109A (es) 2020-07-27 2023-04-24 Anjarium Biosciences Ag Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas.
US20220243201A1 (en) * 2020-08-23 2022-08-04 Bioverativ Therapeutics Inc. Engineered itr sequences and methods of use
MX2023003019A (es) * 2020-09-16 2023-05-08 Generation Bio Co Vectores de adn de extremo cerrado y usos de estos para expresar fenilalanina hidroxilasa (pah).
GB202014751D0 (en) 2020-09-18 2020-11-04 Lightbio Ltd Targeting vector
GB202014772D0 (en) 2020-09-18 2020-11-04 Lightbio Ltd Nucleic acid construct
CA3209115A1 (en) * 2021-01-25 2022-07-28 Prevail Therapeutics, Inc. Modulation of aav-based gene expression
CN112980862A (zh) * 2021-02-25 2021-06-18 通用生物系统(安徽)有限公司 一种高纯度微环dna的制备方法
JP2024517427A (ja) 2021-04-20 2024-04-22 アンジャリウム バイオサイエンシズ エージー アミロ-α-1,6-グルコシダーゼ、4-α-グルカノトランスフェラーゼをコードするDNA分子の組成物、その作製の方法、及びその使用の方法
US20240216535A1 (en) * 2021-04-27 2024-07-04 Generation Bio Co. Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
JP2024515788A (ja) * 2021-04-27 2024-04-10 ジェネレーション バイオ カンパニー 治療抗体を発現する非ウイルスdnaベクター及びその使用
WO2022236016A1 (en) * 2021-05-07 2022-11-10 Generation Bio Co. Lyophilized non-viral dna vector compositions and uses thereof
EP4333886A4 (en) * 2021-05-07 2025-11-12 Generation Bio Co NON-VIRAL DNA VECTORS FOR VACCINE ADMINISTRATION
US20250049961A1 (en) * 2021-12-23 2025-02-13 Generation Bio Co. Scalable and high-purity cell-free synthesis of closed-ended dna vectors
WO2023135273A2 (en) 2022-01-14 2023-07-20 Anjarium Biosciences Ag Compositions of dna molecules encoding factor viii, methods of making thereof, and methods of use thereof
GB202204112D0 (en) 2022-03-23 2022-05-04 Lightbio Ltd Linear construct
EP4293101A1 (en) 2022-06-14 2023-12-20 Asklepios Biopharmaceutical, Inc. Reactor with temperature control and method of using the same
JP2025525583A (ja) 2022-07-19 2025-08-05 ランパート バイオサイエンス インコーポレイテッド 非免疫原性環状非ウイルス性dnaベクター
WO2024040222A1 (en) 2022-08-19 2024-02-22 Generation Bio Co. Cleavable closed-ended dna (cedna) and methods of use thereof
US20260199386A1 (en) * 2022-12-01 2026-07-16 Generation Bio Co. Synthetic single-stranded dna molecules and methods of producing and using the same
WO2024170778A1 (en) 2023-02-17 2024-08-22 Anjarium Biosciences Ag Methods of making dna molecules and compositions and uses thereof
US11993783B1 (en) * 2023-03-27 2024-05-28 Genecraft Inc. Nucleic acid molecule comprising asymmetrically modified ITR for improving expression rate of inserted gene, and use thereof
WO2026085495A1 (en) 2024-10-18 2026-04-23 Generation Bio Co. Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US6346415B1 (en) * 1997-10-21 2002-02-12 Targeted Genetics Corporation Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors
AU2002365514A1 (en) 2001-11-30 2003-06-10 Innogenetics N.V. Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
EP3176263A1 (en) * 2007-08-10 2017-06-07 Toto Ltd. Method of producing recombinant mammalian cells
US8709778B2 (en) * 2008-10-28 2014-04-29 Xavier Danthinne Method of adenoviral vector synthesis
EP2500434A1 (en) 2011-03-12 2012-09-19 Association Institut de Myologie Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
EP2970966A4 (en) * 2013-03-15 2016-10-26 Univ North Carolina SYNTHETIC ADENOASSOZED VIRUS INVERTED REPEAT SEQUENCES
IL261524B2 (en) * 2016-03-03 2023-10-01 Univ Massachusetts End-capped linear double-stranded DNA for non-viral gene transfer
WO2019101596A1 (en) 2017-11-21 2019-05-31 Expedeon Ltd Methods and kits for amplification of double stranded dna
AU2019221642A1 (en) 2018-02-14 2020-07-09 Generation Bio Co. Non-viral DNA vectors and uses thereof for antibody and fusion protein production
KR20210119416A (ko) * 2019-01-24 2021-10-05 제너레이션 바이오 컴퍼니 폐쇄-말단 dna (cedna), 및 유전자 또는 핵산 치료 관련 면역 반응을 감소시키는 방법에서의 이의 용도
WO2021011842A1 (en) * 2019-07-17 2021-01-21 Generation Bio Co. Synthetic production of single-stranded adeno associated viral dna vectors
US20220228171A1 (en) * 2019-07-17 2022-07-21 Generation Bio Co. Compositions and production of nicked closed-ended dna vectors

Similar Documents

Publication Publication Date Title
JP2023126487A5 (cg-RX-API-DMAC7.html)
JP7860174B2 (ja) 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター
JP2022530544A5 (cg-RX-API-DMAC7.html)
CA3233336A1 (en) Circular rna and preparation method thereof
KR20240113624A (ko) Aav 캡시드 변이체 및 이의 용도
JP2022530633A5 (cg-RX-API-DMAC7.html)
JP2022530656A5 (cg-RX-API-DMAC7.html)
AU2023217698A1 (en) Aav capsid variants and uses thereof
CA3092459A1 (en) Closed-ended dna (cedna) vectors for insertion of transgenes at genomic safe harbors (gsh) in humans and murine genomes
JP7481755B2 (ja) 組換えパルボウイルスベクターならびにその作製および使用方法
JP2022529065A5 (cg-RX-API-DMAC7.html)
WO2022159402A1 (en) Composition and method for high-multiplexed genome engineering using synthetic crispr arrays
JP7489112B2 (ja) Crisprタイプi-dシステムを利用した標的配列改変技術
WO2025102994A1 (zh) 基于i型内含子的rna体外环化与滚环翻译的方法及其应用
CN113950530A (zh) 核酸多联体产物的表达
CA3206298A1 (en) Functional nucleic acid molecule and method
US9012620B2 (en) DNA constructs for specific inhibition of gene expression by RNA interference
JP2025510714A (ja) 遺伝子編集用のrnaフレームワーク及び遺伝子編集方法
AU2022399440A1 (en) Functional aav capsids for intravitreal administration
JP2024521750A5 (cg-RX-API-DMAC7.html)
AU784832B2 (en) Self-cleaving RNA sequences and their use for the control of protein synthesis
RU2020127017A (ru) ДНК-ВЕКТОРЫ С ЗАМКНУТЫМИ КОНЦАМИ, ПОЛУЧАЕМЫЕ ПУТЕМ БЕСКЛЕТОЧНОГО СИНТЕЗА, И СПОСОБ ПОЛУЧЕНИЯ зкДНК-ВЕКТОРОВ
US20260103702A1 (en) Compositions and methods for crispr modulation
WO2025072763A2 (en) Compositions and methods for precision editing with cas dimers
JP2025530419A (ja) フォールディングオリゴヌクレオチド